Benitec Biopharma BNTC

$ 11.75 -0.34%

Quarterly report 2025-Q3
added 11-14-2025

Benitec Biopharma DPO Ratio 2011-2026 | BNTC

Annual DPO Ratio Benitec Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-556	1.26 K	469	233	1.41 K	6.94 K	6.94 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.94 K	-556	2.38 K

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	Amarin Corporation plc AMRN	190	$ 15.08	2.24 %	$ 6.15 B	Irlanda
	Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	Aptorum Group Limited APM	405	$ 0.84	2.78 %	$ 4.58 M	China
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
	Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
	Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	Arena Pharmaceuticals ARNA	142	-	-6.81 %	$ 3.04 B	USA
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	Amneal Pharmaceuticals AMRX	21.1	$ 14.79	1.83 %	$ 4.57 B	USA
	AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
	Codexis CDXS	98.4	$ 1.26	-1.94 %	$ 92.5 M	USA
	Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
	Aytu BioScience AYTU	186	$ 2.33	1.75 %	$ 14.6 M	USA